Sign in

Kerala coronavirus patients recovered without drugs: Expert

The fixed dose combination of anti-HIV drugs— Lopinavir and Ritonavir — has been used with other drugs in China with varying results, but not in India yet.

Updated on: Mar 8, 2020, 05:20:19 IST
Hindustan Times, New Delhi | By
Share
Share via
  • facebook
  • twitter
  • linkedin
Copy link
  • copy link

The three people from Kerala who contracted coronavirus (Covid-19) recovered without the use of any drugs, and India has adequate supply of the combination of two antiretroviral drugs used to treat HIV and AIDS and are being used to treat Sars-CoV-2, said a scientist at one of the labs run by the Indian Council of Medical Research (ICMR) on the condition of anonymity.

Medical staff carry medical waste at Kochi Medical college in Kerala on February . (PTI photo)
Medical staff carry medical waste at Kochi Medical college in Kerala on February . (PTI photo)

The fixed dose combination of anti-HIV drugs— Lopinavir and Ritonavir — has been used with other drugs in China with varying results, but not in India yet.

“The combination has shown some promise against the virus but it doesn’t mean it will work 100% in all cases. Like others globally, we also did some computerised studies for repurposing a drug to see which among the available molecules works against the virus, and affects its replication. The Lopinavir and Ritonavir combination looked promising,” said the scientist.

The Drug Controller General of India last month approved its restricted use, keeping in view the public health emergency situation that was likely to emerge with cases rising worldwide.

“As an emergency public health measure this can be given to symptomatic patients; about two tablets a day of 400mg dosage for about 14 days is what we advise. It’s a fixed dose combination, which means a single tablet will have both the medicines. It has not been given to anyone so far in India, most patients are on supportive therapy, and stable,” the ICMR scientist added.

In a study published in the Journal of the American Medical Association (JAMA) last week, researchers presented a case series of 18 patients with SARS-CoV-2 in Singapore.

“Five patients who required supplemental oxygen also received lopinavir-ritonavir: three experienced a reduction in the need for supplemental oxygen within three days, while two saw their condition worsen. For all patients, the median duration of viral shedding was 12 days,” according to the research.

  • Rhythma Kaul
    ABOUT THE AUTHOR
    Rhythma Kaul

    Rhythma Kaul is the national health editor of the Hindustan Times. She has been reporting on public health, medicine, and medical research, with a particular focus on how government decisions and health system reforms shape people’s lives. Rhythma has over 25 years of journalistic experience. She joined Hindustan Times in 2008, and has since covered everything from pandemics and infectious diseases to cutting‑edge medical research and climate‑related health challenges. Her stories routinely track the work of the Ministry of Health and Family Welfare, department of pharmaceuticals, and key national health programmes, making complex medical science and policy accessible to a wide audience. One of her prominent news breaks has been the 2012 Baby Falak case: A two-year-old brutally battered baby girl was admitted to AIIMS-Delhi with severe head injuries, multiple fractures, human bite marks, and burns. The police investigation revealed this to be a case of multi-state human-trafficking racket. She was profiled by The Wall Street Journal for breaking this story. Rhythma holds a Master’s degree from Jawaharlal Nehru University, Delhi. Prior to Hindustan Times, she worked with the India Today Group. Rhythma can be contacted at rhythma.kaul@hindustantimes.com. Her X handle is @RamblingBrook.Read More